AspenBio Pharma (APPY) announces a secondary offering for an undisclosed amount of its common...

|By:, SA News Editor

AspenBio Pharma (APPY) announces a secondary offering for an undisclosed amount of its common stock. The company intends to use the net proceeds for general corporate purposes, which includes conducting a clinical trial for its blood-based appendicitis test, and for working capital purposes. Aegis Capital is acting as the sole book-running manager for the offering. Shares -8.5% AH.